BMO Capital upgrades Sabra Health Care REIT to Market Perform and price target to $19
BMO Capital took its Sabra Health Care REIT [SBRA] rating to the equivalent of Market Perform from Underperform, and the price target to $19.0, in a research note dated 2021-01-08. That figure represents around a 11.6% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with JMP Securities’s analysts […]
